Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
55,705,828
-
Total 13F shares
-
10,814,039
-
Share change
-
+439,100
-
Total reported value
-
$103,976,595
-
Price per share
-
$9.61
-
Number of holders
-
60
-
Value change
-
+$4,167,628
-
Number of buys
-
34
-
Number of sells
-
16
Institutional Holders of Spero Therapeutics, Inc. - Common Stock, par value $0.001 per share (SPRO) as of Q4 2019
As of 31 Dec 2019,
Spero Therapeutics, Inc. - Common Stock, par value $0.001 per share (SPRO) was held by
60 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,814,039 shares.
The largest 10 holders included
Atlas Venture Associates IX, LLC, Aquilo Capital Management, LLC, Alphabet Inc., Novo Holdings A/S, BVF INC/IL, BlackRock Inc., Rock Springs Capital Management LP, Artal Group S.A., VANGUARD GROUP INC, and AWM Investment Company, Inc..
This page lists
60
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.